About AffyImmune Therapeutics
founded in 2016, affyimmune is a clinical-stage biotechnology company that optimizes car t cells for the treatment of solid tumors using our tune & track platform. aic100, our first ... Read more
founded in 2016, affyimmune is a clinical-stage biotechnology company that optimizes car t cells for the treatment of solid tumors using our tune & track platform. aic100, our first ... Read more